SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014087
Filing Date
2024-05-22
Accepted
2024-05-22 16:17:23
Documents
2
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 form4-05222024_080510.html 4  
1 form4-05222024_080510.xml 4 5929
2 ex24-05222024_080510.htm EX-24 7023
  Complete submission text file 0001415889-24-014087.txt   14428
Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98011
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 24973503

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)